Gsa Capital Partners LLP Kala Pharmaceuticals, Inc. Transaction History

Gsa Capital Partners LLP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.3 - $1.31 $4,263 - $18,615	-14,210 Reduced 52.27%	12,975 $4,000
Q1 2022 May 11, 2022	BUY	$0.61 - $1.84 $16,582 - $50,020	27,185 New	27,185 $38,000
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $29,434 - $69,527	-25,375 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$2.62 - $5.43 $66,482 - $137,786	25,375 New	25,375 $66,000
Q2 2021 Aug 05, 2021	SELL	$5.06 - $8.15 $117,311 - $188,949	-23,184 Closed	0 $0

Q1 2021 May 10, 2021	BUY	$6.24 - $9.58 $79,048 - $121,359	12,668 Added 120.46%	23,184 $156,000
Q4 2020 Feb 03, 2021	BUY	$6.28 - $8.79 $66,040 - $92,435	10,516 New	10,516 $71,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.